{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:10:17Z","timestamp":1760267417894},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OTT"],"DOI":"10.2147\/ott.s102504","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T19:24:48Z","timestamp":1470857088000},"page":"4937-4957","source":"Crossref","is-referenced-by-count":12,"title":["Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned"],"prefix":"10.2147","volume":"Volume 9","author":[{"given":"Beth","family":"Linder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Pinilla-Ibarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendra","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Corrales-Yepez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami","family":"Komrokji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,8]]},"container-title":["OncoTargets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=31836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T19:00:58Z","timestamp":1477854058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/role-of-tyrosine-kinase-inhibitors-in-myeloproliferative-neoplasms-com-peer-reviewed-article-OTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ott.s102504","relation":{},"ISSN":["1178-6930"],"issn-type":[{"value":"1178-6930","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}